Skip to main content

BioMedInnovations, LLC – Winston-Salem, NC – May 22, 2022

Using BioMedInnovations´ patented cardio-vascular waveform emulating CaVESWave® organ and tissue perfusion platform, Dr. Lake-Bakaar and his team will use perfuse cirrhotic human liver explants directly removed from patients at the time of transplantation, thereby providing a unique opportunity for the study of blood flow regulation in disease states.

The research team will reproduce experiments describing the dose-responsive effects of obeticholic acid in porcine livers using explant human cirrhotic livers.